title: Cancer- and treatment-related anemia.
authors.forename: George M
authors.initials: GM
authors.lastname: Rodgers
authors.forename: David
authors.initials: D
authors.lastname: Cella
authors.forename: Asher
authors.initials: A
authors.lastname: Chanan-Khan
authors.forename: Carolyn
authors.initials: C
authors.lastname: Chesney
authors.forename: Charles
authors.initials: C
authors.lastname: Cleeland
authors.forename: Peter F
authors.initials: PF
authors.lastname: Coccia
authors.forename: George D
authors.initials: GD
authors.lastname: Demetri
authors.forename: Benjamin
authors.initials: B
authors.lastname: Djulbegovic
authors.forename: Jennifer L
authors.initials: JL
authors.lastname: Garst
authors.forename: Margaret
authors.initials: M
authors.lastname: Gore
authors.forename: Eric H
authors.initials: EH
authors.lastname: Kraut
authors.forename: Weei-Chin
authors.initials: WC
authors.lastname: Lin
authors.forename: Michael
authors.initials: M
authors.lastname: Millenson
authors.forename: Victoria
authors.initials: V
authors.lastname: Mock
authors.forename: Denise
authors.initials: D
authors.lastname: Reinke
authors.forename: Joseph
authors.initials: J
authors.lastname: Rosenthal
authors.forename: Paul
authors.initials: P
authors.lastname: Sabbatini
mesh_terms: D000740:Anemia / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D001803:Blood Transfusion; D002986:Clinical Trials as Topic; D004921:Erythropoietin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D005544:Forecasting; D017408:Guidelines as Topic; D006397:Hematinics / Q000009:adverse effects / Q000627:therapeutic use*; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D015994:Incidence; D009369:Neoplasms / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D011788:Quality of Life; D016896:Treatment Outcome
chemical_list: D006397:Hematinics; D006454:Hemoglobins; D004921:Erythropoietin